BellRing Brands (BRBR)
(Real Time Quote from BATS)
$58.85 USD
-1.04 (-1.74%)
Updated May 15, 2024 11:06 AM ET
1-Strong Buy of 5 1
D Value D Growth B Momentum D VGM
BellRing Brands (BRBR) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$64.21 | $70.00 | $50.00 | 7.21% |
Price Target
Based on short-term price targets offered by 14 analysts, the average price target for BellRing Brands comes to $64.21. The forecasts range from a low of $50.00 to a high of $70.00. The average price target represents an increase of 7.21% from the last closing price of $59.89.
Analyst Price Targets (14)
Broker Rating
BellRing Brands currently has an average brokerage recommendation (ABR) of 1.50 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 15 brokerage firms. The current ABR compares to an ABR of 1.54 a month ago based on 14 recommendations.
Of the 15 recommendations deriving the current ABR, 10 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 66.67% and 13.33% of all recommendations. A month ago, Strong Buy made up 64.29%, while Buy represented 14.29%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 10 | 10 | 9 | 10 | 10 |
Buy | 2 | 2 | 2 | 2 | 2 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.50 | 1.50 | 1.54 | 1.50 | 1.50 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
5/8/2024 | Mizuho SecuritiesUSA | John J Baumgartner | Strong Buy | Strong Buy |
5/8/2024 | Evercore Partners | David Palmer | Strong Buy | Strong Buy |
5/7/2024 | William Blair | Jon R Andersen | Strong Buy | Strong Buy |
5/7/2024 | Stephens | Jim Salera | Hold | Hold |
5/7/2024 | Needham & Company | Matthew R Mcginley | Moderate Buy | Moderate Buy |
1/3/2024 | Truist Securities | William B Chappell | Strong Buy | Hold |
12/12/2023 | D.A. Davidson | Brian Holland | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.50 |
ABR (Last week) | 1.50 |
# of Recs in ABR | 15 |
Average Target Price | $64.21 |
LT Growth Rate | 17.10% |
Industry | Medical - Products |
Industry Rank by ABR | 145 of 252 |
Current Quarter EPS Est: | 0.44 |